Human Medicine:

FAECAL IMMUNOCHEMICAL TESTING (FIT)

Bowel / colorectal cancer screening test

SYNLAB’s new Faecal Immunochemical Testing (FIT) is a bowel / colorectal cancer screening test.

FIT is a more sensitive screening test which selectively detects the human globin-protein in stool, making it specific to colonic blood loss.

  • Bowel cancer is the UK’s 2nd biggest cancer killer – early diagnosis saves lives.*
  • Non invasive home test kit – only 1 stool sample needed.
  • Supports NICE DG30 guidelines.
  • Samples sent directly by patient to the laboratory.

SYNLAB’s new FIT kits include everything a patient needs to do the screening test in the privacy of their own home.

To discuss adding FIT kits and screening test to your account, please contact Customer Services on 01873 856688 or [email protected].

FIT screening is for asymptomatic patients – patients experiencing bowel cancer symptoms should seek medical advice. Further information about bowel cancer can be found at: www.bowelcanceruk.org.uk

*Source: Bowel Cancer UK

Latest Human Medicine News
SYNLAB launch Faecal Immunochemical Testing (FIT)

23rd July 2019 – SYNLAB have announced the launch of Faecal Immunochemical Testing (FIT), a bowel / colorectal cancer screening test. FIT is a more…

Read More (about 'SYNLAB launch Faecal Immunochemical Testing (FIT)')
Leukaemia patient goes behind the scenes at The Christie Pathology Partnership

As part of National Biomedical Science Day, the Christie Pathology Partnership (CPP), based at The Christie in Manchester, opened its doors and gave a special…

Read More (about 'Leukaemia patient goes behind the scenes at The Christie Pathology Partnership')
Healthcare Science – an insight into working at Pathology First

Matt Jeffery, Operations Manager at Pathology First explains how he achieved his role, how the profession is evolving and what it’s like to lead the…

Read More (about 'Healthcare Science – an insight into working at Pathology First')
Healthcare Science Week – what’s it like being a Biomedical Scientist (BMS) at Europe’s largest cancer centre?

Jamie Wild is a Biomedical Scientist (BMS) at the Christie Pathology Partnership (CPP), one of the UK’s leading reference centres specialising in cancer detection and…

Read More (about 'Healthcare Science Week – what’s it like being a Biomedical Scientist (BMS) at Europe’s largest cancer centre?')